Xcout Intel
TYBR Health, Inc.
TYBR Health, Inc. is a medical device and regenerative medicine company founded in 2020 that specializes in developing products to improve post-operative surgical recovery.
Subscribe to see TYBR Health, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
TYBR Health, Inc. at a glance
TYBR Health, Inc. is a medical supplies company headquartered in United States. Its most recent funding round raised $14.4M in July 2026. Xcout tracks 14 named people at TYBR Health, Inc., including Timothy J. Keane (Chief Executive Officer).
TYBR Health, Inc. leadership
- Timothy J. KeaneChief Executive Officer
- Alex SmithExecutive Officer
- Timothy J. Keane, Jr.Executive Officer
- Timothy KeaneExecutive Officer
- Aaron SmithDirector
- Alex J. SmithDirector
8 more named people on record for TYBR Health, Inc., with roles, board committees and tenure — see the full roster →
TYBR Health, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $14.4M | — | |
| Series A | $30M | 3 named | |
| SEC Form D filing | $7.1M | — | |
| SEC Form D filing | $709,999 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
TYBR Health, Inc. competitors
A few of TYBR Health, Inc.'s closest competitors — see the full list of competitors and alternatives →
Riverpoint Medical designs, develops, and markets next-generation medical devices, operating with its corporate headquarters and manufacturing facilities located in Portland, Oregon.
Tiger Biotherapeutics Inc. is a regenerative medicine company that develops and provides advanced cellular, acellular, and matrix-like products (CAMPs) for wound care, aesthetics, and tissue science. The company serves healthcare providers and patients by offering solutions for tissue repair, wound closure, and reconstructive or cosmetic applications.
Tissue Regenix is a medical technology company that develops and manufactures regenerative products, including allografts and xenografts. Using its proprietary dCELL and BioRinse platform technologies, the company provides musculoskeletal, dermis, soft tissue, and birth tissue products to hospitals and medical professionals to support patient recovery.
MicroVascular Tissues, Inc. is a regenerative tissue company based in San Diego, California, developing medical products targeting microvascular conditions.
Tempo Therapeutics is an innovator in tissue engineering and regenerative medicine based in San Diego, California. The company secured Series A financing to advance its proprietary biomedical therapeutic products.
Get TYBR Health, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about TYBR Health, Inc.? Suggest a correction · Work at TYBR Health, Inc.? Claim this profile
Is this your company? Add the Xcout Intel badge to your website
Free, for any company on Xcout Intel. It links visitors to this profile.
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on TYBR Health, Inc. in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access